← Leaderboards

Ozioma C Okonkwo

University Of Wisconsin-Madison

Google Scholar ↗PubMed ↗ORCID ↗

$15,658,168

Attributed

$71,169,088

Total exposure

7

Grants

6

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $32.5M · FY2013–25

$50M$37.5M$25M$12.5M$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$71,169,088 · 7

By mechanism

U01$60,357,563 · 1

R01$8,366,667 · 3

U19$1,120,553 · 1

K23$883,615 · 1

R21$440,690 · 1

Top collaborators

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposBiological MarkersS DiseaseCohortCognitiveAdultAlzheimer Disease PreventionWisconsinS Disease RiskPositron-Emission TomographyAgingMiddle AgeSymptomsElderlyNerve DegenerationRegistriesLinkPublic HealthMagnetic Resonance ImagingEpidemicEnrollmentProspectiveFutureGenetic Risk

Grant awards (22)

Sleep and Aerobic Fitness as Midlife Modifiers of Later Life Cognitive Decline and Alzheimer's Disease Biomarkers in the Wisconsin Sleep Cohort$756,633

R01 · FY2025 · AG · contact PI

KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD$755,566

R01 · FY2025 · AG

ADRC Consortium for Clarity in ADRD Research Through Imaging$29,557,545

U01 · FY2024 · AG

KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD$777,480

R01 · FY2024 · AG

Sleep and Aerobic Fitness as Midlife Modifiers of Later Life Cognitive Decline and Alzheimer's Disease Biomarkers in the Wisconsin Sleep Cohort$772,992

R01 · FY2024 · AG · contact PI

ADRC Consortium for Clarity in ADRD Research Through Imaging$30,800,018

U01 · FY2023 · AG

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$928,957

R01 · FY2023 · AG · contact PI

KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD$777,477

R01 · FY2023 · AG · contact PI

HABS-HD - Core G - Development Core$1,120,553

U19 · FY2022 · AG · contact PI

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$930,944

R01 · FY2022 · AG · contact PI

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$931,389

R01 · FY2021 · AG · contact PI

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$772,833

R01 · FY2020 · AG · contact PI

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$190,081

R01 · FY2020 · AG · contact PI

Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort$772,315

R01 · FY2019 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$162,800

K23 · FY2017 · AG · contact PI

Genetic and Lifestyle Determinants of Cognitive Resilience in Midlife$116,107

R21 · FY2017 · AG · contact PI

Genetic and Lifestyle Determinants of Cognitive Resilience in Midlife$324,583

R21 · FY2016 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$162,800

K23 · FY2016 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$69,615

K23 · FY2016 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$162,800

K23 · FY2015 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$162,800

K23 · FY2014 · AG · contact PI

Early detection of asymptomatic middle-age adults at risk for AD$162,800

K23 · FY2013 · AG · contact PI